Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-25-054856

Chief Executive Officer gave up 16,570 shares (to pay taxes)

  • Chief Executive Officer acquired 375 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hardy Alexander · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-30 Grant or award : show line 1 in the form +375 $54.14 $20,301 175,958 D
2025-12-01 Shares withheld for taxes : show line 2 in the form −16,570 $55.03 $911,847 159,388 D
Loading xslF345X05/wk-form4_1764718145.xml…